Firefly Neuroscience (AIFF) Stock Price, News & Analysis

Company Overview

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Key Stats

• Today's Range: $3.08 to $3.19
• 50-Day Range: $2.74 to $4.11
• 52-Week Range: $1.86 to $17.20
• Volume: 96,378 shs
• Average Volume: 2.95 million shs
• Market Capitalization: $40.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AIFF Stock Analysis - Frequently Asked Questions

How have AIFF shares performed this year?

Firefly Neuroscience's stock was trading at $2.65 at the start of the year. Since then, AIFF shares have increased by 18.9% and is now trading at $3.15.
View the best growth stocks for 2025 here.

How were Firefly Neuroscience's earnings last quarter?

Firefly Neuroscience, Inc. (NASDAQ:AIFF) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($1.30) EPS for the quarter. Firefly Neuroscience had a negative trailing twelve-month return on equity of 276.50% and a negative net margin of 73.72%.

When did Firefly Neuroscience's stock split?

Firefly Neuroscience shares reverse split on the morning of Tuesday, August 13th 2024. The 1-3 reverse split was announced on Friday, August 9th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

Who are Firefly Neuroscience's major shareholders?

Top institutional shareholders of Firefly Neuroscience include FNY Investment Advisers LLC (0.20%).
View institutional ownership trends.

How do I buy shares of Firefly Neuroscience?

Shares of AIFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Firefly Neuroscience own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Firefly Neuroscience investors own include Broadcom (AVGO), Paylocity (PCTY), Analog Devices (ADI), Advanced Micro Devices (AMD), ASML (ASML), Baidu (BIDU) and Bruker (BRKR).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 6/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Prepackaged software
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:AIFF
• Previous Symbol: NASDAQ:AIFF
• CIK: 803578
• Web: fireflyneuro.com
• Phone: (888) 237-6412
• Fax: 703-293-7979
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.94)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.03 million
• Net Margins: -73.72%
• Pretax Margin: -74.29%
• Return on Equity: -276.50%
• Return on Assets: -133.02%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.05
• Quick Ratio: 1.05

Sales & Book Value

• Annual Sales: $139,000.00
• Price / Sales: 287.75
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.38 per share
• Price / Book: 0.92

Miscellaneous

• Outstanding Shares: 12,861,000
• Free Float: 7,275,000
• Market Cap: $40.00 million
• Optionable: N/A
• Beta: 3.22